LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Niconex Medical joins EuropaBio: Driving Regulatory Insight Within European Biotech

    13/03/2026

    PRESS RELEASE

    Brussels, 13 March 2026 – EuropaBio is pleased to welcome its newest member, Niconex Medical.

    Founded in 2017 and based in Cyprus, Niconex Medical operates through two core pillars: Regulatory & Vigilance and Research & Innovation. Through its Regulatory & Vigilance services, the company provides local Regulatory Affairs and Pharmacovigilance support for Human Medicines and Biocidal products, both for products already on the market and for those seeking entry to the Cypriot market.

    Under its Research & Innovation pillar, Niconex offers project coordination, regulatory and patentability research, as well as exploitation, dissemination and communication activities tailored to specific project needs. With a strong focus on Life Sciences and Health Biotechnology, Niconex’s work aligns closely with EuropaBio’s priorities and advocacy efforts across the EU biotechnology landscape.

    By joining EuropaBio, Niconex aims to remain at the forefront of legislative and regulatory developments, strengthening support for its clients and contributing to policy conversations that shape the future of the European biotech sector. The company is committed to sharing evidence and expertise from its regulatory and research activities, while also representing the perspectives and frameworks of smaller Member States such as Cyprus.

    Dr Claire Skentelbery, Director General of EuropaBio, commented: “It is excellent to welcome Nicolas and Niconex Medical into EuropaBio. Sector and regulatory expertise in healthcare are at the core of our strength, and we look forward to a impactful 2026 together.”

    Dr Nicolas Constantinou, Director at Niconex Medical, said: “The opportunity to be a part of EuropaBio is invaluable, especially as a small consultancy; it is with sincere gratitude and pleasure to be involved along with esteemed peers at the frontier of European biotech ecosystem, and in parallel, pave a way forward that remains adhered to Niconex core values of integrity, transparency, urgency and quality.”

    For more information, please visit niconex.eu

    Niconex Medical joins EuropaBio: Driving Regulatory Insight Within European Biotech


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    03/04/2026

    Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture


    Read more
    02/04/2026

    The EU Biotech Act II: A vital Act for biomanufacturing in Europe


    Read more
    31/03/2026

    Nestlé joins EuropaBio: Driving Innovation for Sustainable Food Systems


    Read more

    Important links

    • Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture
    • The EU Biotech Act II: A vital Act for biomanufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.